Hey DD, happy holders indeed> Bristol-Myers Squibb Co has agreed to acquire Inhibitex Inc for about $2.5 billion to gain access to its promising hepatitis C treatment, the companies said on Saturday. If I'd had any idea how strong the upward move was going to be I would have bought way more under $10 I got a heads up thurs nov 3rd...when it was still under $4.00
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.